- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
Nasdaq
Wall Street JournalEN
A
AUTL
AUTOLUS THERAPEUTICS PLC
1.67
0.03+1.83%After Hours: 1.660 -0.01 -0.60%19:44 02/20 EST
OPEN/PREV CLOSE1.650/1.640
TODAY RANGE1.580-1.700
VOL2.21M
MARKET CAP444.46M
52 WEEK RANGE1.105-2.700
AVG VOL (3M)2.69M
% TURNOVER0.83%
TURNOVER--
P/E (TTM)-1.9773
% RANGE7.28%
EPS(TTM)-0.8446
P/E(FORWARD)-1.6869
P/B1.390
BVPS1.302
DIVIDEND--
P/S41.80
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP412.02M
SHARES OUTSTANDING266.14M
NEXT EARNINGS03/18-03/23
FREE FLOAT246.72M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·2d ago
Spotlight On Silence Therapeutics And 2 Other Promising Penny Stocks
TipRanks·4d ago
Autolus Therapeutics initiated with a Buy at H.C. Wainwright
TipRanks·02/13 11:43
Autolus Therapeutics price target lowered to $8 from $11 at H.C. Wainwright
TipRanks·02/04 14:01
Autolus Therapeutics reports inducement grants under Nasdaq listing rule
Simply Wall St·02/03 13:49
The Market Doesn't Like What It Sees From Autolus Therapeutics plc's (NASDAQ:AUTL) Revenues Yet As Shares Tumble 26%
TipRanks·01/26 21:32
Autolus Therapeutics Signs Long-Term Lentiviral Supply Agreement
Simply Wall St·01/21 11:05
3 Promising Penny Stocks With Market Caps Over $70M
TipRanks·01/17 14:26
Wells Fargo Keeps Their Buy Rating on Autolus Therapeutics (AUTL)
Benzinga·01/14 10:26
Why Gelteq Shares Are Trading Higher By 50%; Here Are 20 Stocks Moving Premarket
Simply Wall St·01/13 18:14
Autolus Therapeutics (AUTL) Is Down 25.0% After Raising 2026 Revenue Guidance And Advancing Obe-cel Trials
TipRanks·01/13 14:02
Autolus Therapeutics price target lowered to $8 from $10 at Truist
Same Industry
Name/Symbol
Change%
Price